Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial

被引：0
|
作者：
Joshua D. Grill
Chelsea G. Cox
Kristin Harkins
Jason Karlawish
机构：
[1] University of California,Institute for Memory Impairments and Neurological Disorders
[2] Irvine,Institute for Clinical and Translational Science
[3] University of California,Department of Psychiatry and Human Behavior
[4] Irvine,Department of Neurobiology and Behavior
[5] University of California,Department of Medicine
[6] Irvine,Department of Medical Ethics and Health Policy
[7] University of California,Department of Neurology
[8] Irvine,undefined
[9] Penn Memory Center,undefined
[10] University of Pennsylvania,undefined
[11] University of Pennsylvania,undefined
[12] University of Pennsylvania,undefined
[13] University of Pennsylvania,undefined
来源：
Alzheimer's Research & Therapy | / 10卷
关键词：
Disclosure; Preclinical; Asymptomatic; Alzheimer’s disease; Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial
    Grill, Joshua D.
    Cox, Chelsea G.
    Harkins, Kristin
    Karlawish, Jason
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [2] PET amyloid-beta imaging in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Benzinger, Tammie L. S.
    Morris, John C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
  • [3] Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study
    Kjeldsen, Pernille L.
    Parbo, Peter
    Hansen, Kim, V
    Aanerud, Joel F. A.
    Ismail, Rola
    Nissen, Peter H.
    Dalby, Rikke B.
    Damholdt, Malene F.
    Borghammer, Per
    Brooks, David J.
    [J]. AGING BRAIN, 2022, 2
  • [4] Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial
    Ritchie, M.
    Raman, R.
    Ernstrom, K.
    Wang, S.
    Donohue, M. C.
    Aisen, P.
    Henley, D.
    Romano, G.
    Novak, G. P.
    Brashear, H. R.
    Sperling, R. A.
    Grill, J. D.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024,
  • [5] LEARNING AMYLOID PATHOLOGY PROGRESSION FROM LONGITUDINAL PIB-PET IMAGES IN PRECLINICAL ALZHEIMER'S DISEASE
    Hao, Wei
    Vogt, Nicholas M.
    Meng, Zihang
    Hwang, Seong Jae
    Koscik, Rebecca L.
    Johnson, Sterling C.
    Bendlin, Barbara B.
    Singh, Vikas
    [J]. 2020 IEEE 17TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2020), 2020, : 572 - 576
  • [6] Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer's disease
    Farrell, Michelle E.
    Thibault, Emma G.
    Becker, J. Alex
    Price, Julie C.
    Healy, Brian C.
    Hanseeuw, Bernard J.
    Buckley, Rachel F.
    Jacobs, Heidi I. L.
    Schultz, Aaron P.
    Chen, Charles D.
    Sperling, Reisa A.
    Johnson, Keith A.
    [J]. ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5434 - 5449
  • [7] Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease
    Svedberg, Marie M.
    Rahman, Obaidur
    Hall, Hakan
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (04) : 484 - 501
  • [8] PET imaging of amyloid in Alzheimer's disease
    Nordberg, A
    [J]. LANCET NEUROLOGY, 2004, 3 (09): : 519 - 527
  • [9] Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease
    Guruswami SM Sundaram
    Dhruva Dhavale
    Julie L Prior
    Jothilingam Sivapackiam
    Richard Laforest
    Paul Kotzbauer
    Vijay Sharma
    [J]. EJNMMI Research, 5
  • [10] Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease
    Sundaram, Guruswami S. M.
    Dhavale, Dhruva
    Prior, Julie L.
    Sivapackiam, Jothilingam
    Laforest, Richard
    Kotzbauer, Paul
    Sharma, Vijay
    [J]. EJNMMI RESEARCH, 2015, 5
12345